Sarah Boyce, President and CEO at Avidity Biosciences, Inc. (RNA), sold 64,755 shares at $22.80 ($1.5M) on 2022-08-24, disclosed to the SEC on 2022-08-26.
Open-market sale of $1.5M RNA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.80 | 35,045 | $799K | 53.8% |
| 2 | $23.07 | 14,855 | $343K | 23.1% |
| 3 | $23.07 | 14,855 | $343K | 23.1% |
| Total | $22.92 avg | 64,755 | $1.5M | 100% |
| Filing → |
| RNA | SELL | 2025-09-05 | $2.5M | — | Filing → |
| RNA | SELL | 2025-08-29 | $1.2M | — | Filing → |
| RNA | SELL | 2025-03-21 | $2.0M | — | Filing → |